History will Scorn the Cowards who fear Trump! David

New Post Public Reply Private Reply Replies (0) Message Board
dw
120
History will Scorn the Cowards who fear Trump!
David Axelrod Super Tuesday election results reported from CNN's Washington DC bureau on Tuesday, March 1, 2016 in Washington, D.C. Photo by John Nowak/CNN
By David Axelrod, CNN Senior Political Commentator

Updated 2:16 PM ET, Fri December 11, 2020

History will scorn the cowards who meekly complied with Trump's scheme to tarnish and overturn the election -- and honor the many who showed courage and fidelity to the rule of law during this time of trial.


Rudy Giuliani and the Trump legal team have debased themselves, our legal system and democracy by filing one frivolous lawsuit after another, crying fraud on TV -- but not in the courtroom, where evidence is required.
Does Donald Trump really believe he lost the election?
Does Donald Trump really believe he lost the election?
And too many Republican officials, fearful of getting sideways with Trump's base, have dutifully echoed his dishonest charges of vote fraud.
A group of Republican state attorneys general lined up in support of a preposterous eleventh-hour filing from the attorney general of Texas, asking the Supreme Court to overturn the results in four states Trump lost.
The suit was filed without standing, supporting evidence or a colorable argument. Nonetheless, Rep. Mike Johnson of Louisiana circulated an email among his Republican House colleagues urging them to sign an amicus brief in support of this outrageous folly. Trump is "anxiously awaiting the final list" to see who signs on to the amicus brief, Johnson wrote, implying dire consequences for anyone who failed join.
Within 24 hours, more than 100 House Republicans complied.
Supporters of Trump have gone so far as to argue that Republicans may stage a battle on the House floor to reject the Biden electors from contested states, a symbolic gesture that would fail but set a chilling precedent.
Get our free weekly newsletter
Sign up for CNN Opinion's new newsletter.

Join us on Twitter and Facebook

Almost as egregious have been the many Republican members of the House and Senate who have refused to acknowledge Biden's victory and countenanced weeks of delay in the transition.
Through their silence, they have given credence to Trump's blatant lies, which have now gained traction among a large majority of Republicans nationally.
It's crazy, authoritarian stuff. If it were occurring anywhere else, Americans would condemn it as an appalling attempt to undermine democracy.
History will scorn the cowards who meekly complied with Trump's scheme to tarnish and overturn the election -- and honor the many who showed courage and fidelity to the rule of law during this time of trial.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 80

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 14

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 0

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 35

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 21

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 194

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 0

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance

Updated Category News Views 39

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyxis Oncology Focuses on Breakthrough Therapy PYX-201

Updated Category News Views 205

Pyxis Oncology Redirects Focus to Leading Therapy PYX-201 Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotech firm, has announced a significant shift in its strategic direction by prioritizing its lead clinical program, PYX-201. This innovative antibody-drug conjugate (ADC) is engineered to target specific components within the tumor extracellular matrix, aiming...

Continue Reading
Ecovyst's Q3 Performance and Strategic Moves for Growth

Updated Category News Views 98

Ecovyst's Third Quarter Performance and Strategic Insights Ecovyst Inc. (NYSE: ECVT), a notable provider in the chemical industry, recently revealed its financial performance for the third quarter of 2025, showcasing significant progress in its operations and strategic decisions. The company specializes in the production of virgin sulfuric acid and regeneration services,...

Continue Reading
Consumer Interest Grows for Monthly AI Home Assistant Services

Updated Category News Views 447

Consumer Willingness to Invest in AI-Driven Home Solutions Recent research into consumer preferences reveals that a significant portion of the population is ready to embrace AI-assisted smart home technology. Parks Associates' compelling study finds that between 42% and 52% of consumers are inclined to subscribe to a monthly service for an AI smart home assistant that...

Continue Reading
Tuya Smart Introduces Hey Tuya: Revolutionizing Everyday AI Assistants

Updated Category News Views 186

Tuya Smart Unveils Hey Tuya: A Game-Changer in AI Technology In a notable advancement in AI technology, Tuya Smart (NYSE: TUYA) has introduced its innovative platform called Hey Tuya. This next-generation Super AI Life Assistant is set to redefine how individuals interact with artificial intelligence in their daily lives. The initiative represents a significant leap...

Continue Reading
Innovative Food Packaging Concept Redefines Convenience

Updated Category News Views 384

New Approach to Food and Beverage Packaging In an ever-evolving world where efficiency and convenience are paramount, an inventive solution has emerged. An inventor, motivated by the challenges of transporting, preparing, and storing food, has conceptualized an improved packaging design that promises to revolutionize these everyday tasks. Why This Invention Matters This...

Continue Reading